Please assess the completion status of the following clinical trial:

Trial Title: Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 18\~85~* Diagnosed as acute CAS (unstable angina or acute myocardial infarction) and being conducted coronary angiography~* Beck Depression Inventory \> 10 and major or minor depressive disorder by the DSM-IV criteria~* With ability to complete various questionnaires~* Can understand the objective of the study and sign informed consent~Exclusion Criteria:~* Occurrence of acute CAS while the patient was hospitalized for another reason, except for CAS~* Current CAS developed less than 3 months after coronary artery bypass graft procedure~* Uncontrolled hypertension (systolic BP \> 180mmHg or diastolic BP \> 100mmHg)~* Resting heart rate \< 40/min~* Severe physical illnesses threatening life or interfering with the recovery from CAS~* Persistent clinically significant laboratory abnormalities~* Concomitant use of class I antiarrhythmic medications; reserpine, guanethidine, clonidine, or methyldopa; anticonvulsants or neuroleptics~* History of neuropsychiatric illnesses such as dementia, Parkinson's disease, brain tumor, psychoses, alcoholism, and other substance dependence~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Escitalopram (Type: EXPERIMENTAL): None
- Placebo pill (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).